Argus Upgrades Abbvie (ABBV) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| AbbVie (NYSE: ABBV) | Delayed: 294.83 +8.83 (3.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $286.00 | 52 Week High | $68.12 | |||
| Open | $293.95 | 52 Week Low | $50.71 | |||
| Day High | $295.40 | P/E | 63.95 | |||
| Day Low | $283.32 | EPS | $4.61 | |||
| Volume | 8,271,500 | |||||
